News

AHMM designs £1bn pharma centre at King’s Cross

By 2020-08-24T06:00:00

Merck Kings Cross 2

Plans for R&D centre in London’s emerging ‘knowledge quarter’ out for consultation

Pharmaceutical firm Merck has announced plans to build a £1bn R&D centre designed by AHMM opposite King’s Cross station in central London.

Plans for the scheme have gone out to consultation, with construction expected to start next year if given the go ahead by Camden council.

Merck, known as MSD in Europe, first announced in December 2017 that it was planning to build a new research hub in London.

…

This content is available to registered users | Already registered?Login here

You are not currently logged in.

To continue reading this story, sign up for free guest access

Existing Subscriber? LOGIN

REGISTER for free access on selected stories and sign up for email alerts. You get:

  • Up to the minute architecture news from around the UK
  • Breaking, daily and weekly e-newsletters

 

Subscribe to Building Design and you will benefit from:

Gated access promo

  • Unlimited news
  • Reviews of the latest buildings from all corners of the world
  • Technical studies
  • Full access to all our online archives
  • PLUS you will receive a digital copy of WA100 worth over £45

Subscribe now for unlimited access.